iCo Therapeutics (iCo Therapeutics) Dividends per Share : $0.00 (TTM As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Dividends per Share?

iCo Therapeutics's dividends per share for the three months ended in Mar. 2021 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2021 was $0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2021 was 0.00. As of today, iCo Therapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

iCo Therapeutics Dividends per Share Historical Data

The historical data trend for iCo Therapeutics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Dividends per Share Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dividends per Share

Get a 7-Day Free Trial

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of iCo Therapeutics's Dividends per Share

For the Biotechnology subindustry, iCo Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iCo Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iCo Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where iCo Therapeutics's Dividend Yield % falls into.

iCo Therapeutics Dividends per Share Calculation

Dividends paid to per common share.

iCo Therapeutics (GREY:ICOTF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

iCo Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2021 )	/	EPS without NRI (Q: Mar. 2021 )
	=	0	/	-0.076
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

iCo Therapeutics Dividends per Share Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines